Atlas Trials

A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

Clinical trial NCT02094417 · COMPLETED

Trial details

NCT number
NCT02094417
Sponsor
Kyowa Kirin Korea Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2014-04-14
Primary completion
2017-04-24
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.